Form 4: Goosehead Insurance Director McConnon Receives Stock Options
SEC Form 4 Filing
Thomas McConnon, a director at Goosehead Insurance, was granted stock options for 10,000 shares on May 7, 2024.
Summary
- Thomas McConnon, a director of Goosehead Insurance, Inc., received stock options on May 7, 2024.
- The options grant McConnon the right to buy 10,000 shares of Class A Common Stock at an exercise price of $61.01.
- The options vest in 12 equal quarterly installments over three years, beginning from the grant date, subject to continued service.
- Full vesting occurs upon a change in control as defined in the Issuer's Amended and Restated Omnibus Incentive Plan.
- Following the transaction, McConnon directly owns 10,000 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard stock option grant, which is generally viewed as a positive incentive but doesn't necessarily indicate exceptional performance or concern.
Positives
- The granting of stock options to a director aligns their interests with those of the shareholders.
- The vesting schedule incentivizes continued service and commitment to the company's long-term success.
Industry Context
Stock option grants are a common form of executive compensation in the insurance industry, used to attract and retain talent and align management's interests with shareholder value.
Comparison to Industry Standards
- Comparing the vesting schedule and exercise price to similar grants at companies like Brown & Brown or Arthur J. Gallagher could provide context on the competitiveness of this compensation package.
- Reviewing executive compensation reports from these companies would offer a benchmark for Goosehead's practices.
Stakeholder Impact
- The stock option grant could potentially dilute existing shareholders' equity if the options are exercised.
- Employees may view the grant positively as it aligns management's interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 05/07/2024 | Date of the stock options transaction. |
| 05/07/2034 | Expiration date of the stock options. |
| 05/09/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.